BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17634645)

  • 21. Off-axis dose equivalent due to secondary neutrons from uniform scanning proton beams during proton radiotherapy.
    Islam MR; Collums TL; Zheng Y; Monson J; Benton ER
    Phys Med Biol; 2013 Nov; 58(22):8235-51. PubMed ID: 24201018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault.
    Zheng Y; Newhauser W; Klein E; Low D
    Phys Med Biol; 2009 Nov; 54(22):6943-57. PubMed ID: 19887713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of stray neutron doses inside the treatment room from a proton pencil beam scanning system.
    Mojżeszek N; Farah J; Kłodowska M; Ploc O; Stolarczyk L; Waligórski MP; Olko P
    Phys Med; 2017 Feb; 34():80-84. PubMed ID: 28131732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent application of an analytical model for secondary neutron equivalent dose produced in a passive-scattering proton therapy treatment unit.
    Gallagher KJ; Taddei PJ
    Phys Med Biol; 2018 Aug; 63(15):15NT04. PubMed ID: 29978833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial beam size study for passive scatter proton therapy. I. Monte Carlo verification.
    Polf JC; Harvey MC; Titt U; Newhauser WD; Smith AR
    Med Phys; 2007 Nov; 34(11):4213-8. PubMed ID: 18072485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutron H*(10) inside a proton therapy facility: comparison between Monte Carlo simulations and WENDI-2 measurements.
    De Smet V; Stichelbaut F; Vanaudenhove T; Mathot G; De Lentdecker G; Dubus A; Pauly N; Gerardy I
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):417-21. PubMed ID: 24255173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TPD-based evaluation of near threshold mono-energetic proton energies for the (7)Li(p,n)(7)Be production of neutrons for BNCT.
    Bengua G; Kobayashi T; Tanaka K; Nakagawa Y; Unesaki H
    Phys Med Biol; 2006 Aug; 51(16):4095-109. PubMed ID: 16885627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.
    Newhauser W; Fontenot J; Zheng Y; Polf J; Titt U; Koch N; Zhang X; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4569-84. PubMed ID: 17634651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stray neutron radiation exposures from proton therapy: physics-based analytical models of neutron spectral fluence, kerma and absorbed dose.
    Shrestha S; Newhauser WD; Donahue WP; Pérez-Andújar A
    Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35613603
    [No Abstract]   [Full Text] [Related]  

  • 30. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
    Jarlskog CZ; Paganetti H
    Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies.
    Yonai S; Kase Y; Matsufuji N; Kanai T; Nishio T; Namba M; Yamashita W
    Med Phys; 2010 Aug; 37(8):4046-55. PubMed ID: 20879566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monte Carlo modeling of proton therapy installations: a global experimental method to validate secondary neutron dose calculations.
    Farah J; Martinetti F; Sayah R; Lacoste V; Donadille L; Trompier F; Nauraye C; De Marzi L; Vabre I; Delacroix S; Hérault J; Clairand I
    Phys Med Biol; 2014 Jun; 59(11):2747-65. PubMed ID: 24800943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEASUREMENT OF NEUTRON AMBIENT DOSE EQUIVALENT IN PROTON RADIOTHERAPY WITH LINE-SCANNING AND WOBBLING MODE TREATMENT SYSTEM.
    Lee S; Lee C; Shin EH; Cho S; Kim DH; Han Y; Choi DH; Ye SJ; Kim JS
    Radiat Prot Dosimetry; 2017 Dec; 177(4):382-388. PubMed ID: 28444374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of output factor, range, and spread-out bragg peak for proton therapy.
    Kim DW; Lim YK; Ahn SH; Shin J; Shin D; Yoon M; Lee SB; Kim DY; Park SY
    Med Dosim; 2011; 36(2):145-52. PubMed ID: 20599372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.
    Pérez-Andújar A; Newhauser WD; Deluca PM
    Phys Med Biol; 2009 Feb; 54(4):993-1008. PubMed ID: 19147903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers.
    Koch N; Newhauser W
    Radiat Prot Dosimetry; 2005; 115(1-4):159-63. PubMed ID: 16381705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of out-of-field absorbed dose and equivalent dose in proton fields.
    Clasie B; Wroe A; Kooy H; Depauw N; Flanz J; Paganetti H; Rosenfeld A
    Med Phys; 2010 Jan; 37(1):311-21. PubMed ID: 20175494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose.
    Yonai S; Matsufuji N; Kanai T
    Med Phys; 2009 Oct; 36(10):4830-9. PubMed ID: 19928113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An indirect in vivo dosimetry system for ocular proton therapy.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Hérault J
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):373-6. PubMed ID: 24222711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.